Virtual meeting
Via Zoom
Description
This training provides knowledge on xylazine, a CNS depressant, linked to an increasing number of overdose deaths in the US. This describes the physiologic effects of xylazine, manifestations of xylazine intoxication, overdose, communicable infections associated with xylazine use, and wound care for persons injecting xylazine.
NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Tehya Johnson, MSN, AGPCNP-BC
Tehya Johnson, NP graduated from the Massachusetts General Hospital Institute of Health Professions and has been working as a board-certified Adult-Gerontology Primary Care Nurse Practitioner since 2020 at Boston Health Care for the Homeless Program. She also has a B.Sc. in Behavioral Neuroscience from Northeastern University, where she worked in preclinical research related to substance use. She began serving in her current role as the Associate Medical Director of the Harm Reduction Team in 2024 and continues to provide care both on street outreach and in the primary care clinic to those experiencing homelessness and substance use disorders, in addition to her educator role with BMC's Grayken Center for Addiction TTA.
Nancy Regan-Brooks, MSN, FNP, CNM, CARN-AP (she/her)
Nancy is a clinical nurse educator for Boston Medical Center's (BMC) Grayken Center for Addiction Training and Technical Assistances, a nurse practitioner board certified in family medicine and midwifery, and clinically practices at the Community Health Center of Cape Cod. Nancy received a master’s in nursing from the Massachusetts General Hospital Institute of Health Professions, a master’s in midwifery from Frontier Nursing University, and is certified as a Certified Addiction Registered Nurse – Advanced Practice (CARN-AP) through the Addictions Nursing Certification Board.
Objectives
Following this training, participants will have the knowledge to:
- Describe the physiologic effects of xylazine.
- Recognize manifestations of intoxication in persons using xylazine.
- Recall signs of xylazine overdose and appropriate response.
- Identify common skin and soft tissue infections associated with xylazine use.
- Describe practices to decrease risk of skin and soft tissue infections in persons using xylazine.
- Recall methods of wound care for persons injecting xylazine.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS), Opioid Response Network (ORN)
Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation information
Please read the Accreditation Information section of the
training page to learn about the requirements for receiving credit or a certificate of completion.
